Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today issued the following statement after the conclusion of the
Allergenic Products Advisory Committee of the U.S. Food and Drug
Administration (FDA) meeting to discuss GRASTEK (Timothy
grass pollen allergen extract).
Language:
English
Contact:
MerckMedia:Pamela Eisele, 908-423-5042orRobert Consalvo, 908-423-6595orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more